Challenges and solutions to support oncology professionals serving underserved populations with cancer in the United States: Results from the ASCO Serving the Underserved Task Force Journal Article


Authors: Patel, M. I.; Hinyard, L.; Merrill, J. K.; Smith, K. T.; Lei, J.; Carrizosa, D.; Kamaraju, S.; Hlubocky, F. J.; Kalwar, T.; Fashoyin-Aje, L.; Gomez, S. L.; Jeames, S.; Florez, N.; Kircher, S. M.; Tap, W. D.
Article Title: Challenges and solutions to support oncology professionals serving underserved populations with cancer in the United States: Results from the ASCO Serving the Underserved Task Force
Abstract: PURPOSELittle data exist regarding approaches to support oncology professionals who deliver cancer care for underserved populations. In response, ASCO developed the Serving the Underserved Task Force to learn from and support oncology professionals serving underserved populations.METHODSThe Task Force developed a 28-question survey to assess oncology professionals' experiences and strategies to support their work caring for underserved populations. The survey was deployed via an online link to 600 oncology professionals and assessed respondent and patient demographic characteristics, clinic-based processes to coordinate health-related social services, and strategies for professional society support and engagement. We used chi-square tests to evaluate whether there were associations between percent full-time equivalent (FTE) effort serving underserved populations (<50% FTE v ≥50% FTE) with responses.RESULTSOf 462 respondents who completed the survey (77% response rate), 79 (17.1%) were Asian; 30 (6.5%) Black; 43 (9.3%) Hispanic or Latino/Latina; and 277 (60%) White. The majority (n = 366, 79.2%) had a medical doctor degree (MD). A total of 174 (37.7%) had <25% FTE, 151 (32.7%) had 25%-50% FTE, and 121 (26.2%) had ≥50% FTE effort serving underserved populations. Most best guessed patients' sociodemographic characteristics (n = 388; 84%), while 42 (9.2%) used data collected by the clinic. Social workers coordinated most health-related social services. However, in clinical settings with high proportions of underserved patients, there was greater reliance on nonclinical personnel, such as navigators (odds ratio [OR], 2.15 [95% CI, 1.07 to 4.33]) or no individual (OR, 2.55 [95% CI, 1.14 to 5.72]) for addressing mental health needs and greater reliance on physicians or advance practice practitioners (OR, 2.54 [95% CI, 1.11 to 5.81]) or no individual (OR, 1.91 [95% CI, 1.09 to 3.35]) for addressing childcare or eldercare needs compared with social workers. Prioritization of solutions, which did not differ by FTE effort serving underserved populations, included a return-on-investment model to support personnel, integrated health-related social needs screening, and collaboration with the professional society on advocacy and policy.CONCLUSIONThe findings highlight crucial strategies that professional societies can implement to support oncology clinicians serving underserved populations with cancer. © American Society of Clinical Oncology.
Keywords: adult; controlled study; middle aged; united states; clinical practice; neoplasm; neoplasms; clinical assessment; health survey; oncology; health care policy; social status; health service; questionnaire; social support; professional practice; advisory committees; radiation oncology; population; clinical evaluation; medical society; medical oncology; physician; cross-sectional study; personal experience; health care planning; medically underserved area; health disparity; child care; hispanic; vulnerable population; mental health service; social work; asian; medically underserved; work; social worker; demographics; responsibility; health care need; procedures; surgical oncology; investment; online analysis; advisory committee; patient advocacy; humans; human; male; female; article; black person; vulnerable populations; sociodemographics; social needs; surveys and questionnaires; malignant neoplasm; care behavior; social engagement
Journal Title: JCO Oncology Practice
Volume: 20
Issue: 5
ISSN: 2688-1527
Publisher: American Society of Clinical Oncology  
Date Published: 2024-05-01
Start Page: 688
End Page: 698
Language: English
DOI: 10.1200/op.23.00595
PUBMED: 38354324
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Douglas Tap
    375 Tap